GoldHaven Resources Corp.

La Société est engagée dans l'acquisition et l'exploration de propriétés de ressources minérales. Son objectif est de localiser et de développer des propriétés économiques de valeur en métaux précieux et en métaux communs et de mener son programme d'exploration sur la propriété Adam West.

French

GoldHaven Resources Corp.

The Company is engaged in the business of acquiring and exploring mineral resource properties. Its objective is to locate and develop economic precious and base metal properties of merit and to conduct its exploration program on the Adam West Property.  The Adam West Property is comprised of five contiguous mineral claims covering an area of 3,097.60 hectares, located on Vancouver Island, British Columbia, approximately 15 kilometres southwest of the town of Sayward in the Nanaimo Mining Division.

English

Goldblock Capital Inc.

Goldblock Capital Inc. (la «Société») est une société d'exploration dont les activités consistent à acquérir, explorer, développer et, selon le cas, exploiter des propriétés minières. Il est prévu que la société sera principalement active dans le domaine de l'exploration minière en Colombie-Britannique.

French

Goldblock Capital Inc.

Goldblock Capital Inc. (the "Company") is an exploration company whose activities consist of acquiring, exploring, developing, and, as the case may be, operating mining properties. It is anticipated that the Company will be mainly active in the field of mining exploration in British Columbia.

English

Champignon Brands Inc.

Champignon Brands Inc. se spécialise dans la formulation et la distribution finale d'une suite de boissons artisanales infusées aux champignons dans le but de promouvoir la santé et le bien-être holistiques grâce à une alimentation saine. À ce jour, il s'est concentré sur la distribution de sa gamme de produits Vitality Superteas.  

French

Champignon Brands Inc.

Champignon is focused on the formulation and manufacturing of novel ketamine, anaesthetics, and adaptogenic delivery platforms for nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders.

English